EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Therapeutic drug monitoring-guided piperacillin dosing in critically ill patients undergoing continuous renal replacement therapy: a systematic review

Nazatul Adhwa Mohd Rozi, Nor Asyikin Mohd Tahir, Shamin Mohd Saffian, Mohd Makmor-Bakry iD, Aliza Mohamad Yusof, Ruslinda Mustafar, Muhammad Nordin M Saud

Journal of Antimicrobial Chemotherapy · 02.12.2024 · 79 (12) · 3078-3090

DOI: 10.1093/jac/dkae332 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 25.09.2024. Verfasst von Nazatul Adhwa Mohd Rozi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Aziz, 50300 Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Critical Illness, Drug Monitoring, Anti-Bacterial Agents, Piperacillin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Universiti Kebangsaan Malaysia, Geran Galakan Penyelidik Muda.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Continuous renal replacement therapy (CRRT) complicates antibiotic dosing in critically ill patients due to altered pharmacokinetics. The optimal dosing of piperacillin remains unclear. Therapeutic drug monitoring (TDM) can personalize piperacillin therapy and improve outcomes.

Objectives

This review investigates the effects of TDM-guided piperacillin dosing on pharmacokinetic target attainment and clinical outcomes in CRRT patients, analyses correlations with clinical outcomes, provides optimal dosing strategies for piperacillin and identifies future research areas.

Methods

A systematic search of PubMed, Scopus and Web of Science was conducted until December 2023, identifying studies on piperacillin pharmacokinetics and clinical outcomes in adult CRRT patients. Data on study characteristics, piperacillin exposures, TDM use, target attainment rates, mortality and length of stay were extracted. The risk of bias was assessed using the Newcastle–Ottawa Scale.

Results

Eleven observational studies were included. High pharmacokinetic variability was evident, with piperacillin target non-attainment in up to 74% of cases without TDM. Two studies with routine TDM showed increased target attainment rates of 80%–100%. Mortality ranged from 17% to 56%, with supratherapeutic concentrations (≥100 mg/L) associated with higher mortality. The impact of optimized piperacillin exposures on outcomes was inconclusive. Most studies demonstrated a low risk of bias.

Conclusions

TDM-guided piperacillin dosing in CRRT patients improved target attainment rates (≥80%). Mortality rates ranged from 17% to 56%, with inconsistent correlations between drug exposures and survival. Supratherapeutic concentrations were linked to higher mortality. Standardized TDM protocols are needed. Future research should establish clear exposure–response relationships and the impact of TDM on clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessDrug MonitoringAnti-Bacterial AgentsPiperacillinContinuous Renal Replacement TherapyHumansObservational Studies as Topic

Substanzen

Anti-Bacterial AgentsPiperacillin

Autor:innen und Institutionen

  • Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Aziz, 50300 Kuala Lumpur, Malaysia.
  • Faculty of Pharmacy, Universitas Airlangga, PQMM+9Q6, Gedung Nanizar Zaman Joenoes Kampus C UNAIR, Jl. Mulyorejo, Mulyorejo, Surabaya, East Java 60115, Indonesia.
  • Department of Anaesthesiology and Intensive Care, Faculty of Medicine and Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif Kuala Lumpur, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, M…
  • Department of Medicine, Faculty of Medicine and Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif Kuala Lumpur, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.
  • Department of Pharmacy, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif Kuala Lumpur, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.

ORCID-Profile: Mohd Makmor-Bakry

Förderung

  • Universiti Kebangsaan Malaysia
  • Geran Galakan Penyelidik Muda

Zitieren

APA

Mohd Rozi, N. A., Mohd Tahir, N. A., Mohd Saffian, S., Makmor-Bakry, M., Mohamad Yusof, A., Mustafar, R., & M Saud, M. N. (2024). Therapeutic drug monitoring-guided piperacillin dosing in critically ill patients undergoing continuous renal replacement therapy: a systematic review. Journal of Antimicrobial Chemotherapy, 79(12), 3078-3090. https://doi.org/10.1093/jac/dkae332

Vancouver

Mohd Rozi NA, Mohd Tahir NA, Mohd Saffian S, Makmor-Bakry M, Mohamad Yusof A, Mustafar R, et al. Therapeutic drug monitoring-guided piperacillin dosing in critically ill patients undergoing continuous renal replacement therapy: a systematic review. Journal of Antimicrobial Chemotherapy. 2024;79(12):3078-3090. doi:10.1093/jac/dkae332

BibTeX
@article{MohdRozi2024,
  author = {Mohd Rozi, Nazatul Adhwa and Mohd Tahir, Nor Asyikin and Mohd Saffian, Shamin and Makmor-Bakry, Mohd and Mohamad Yusof, Aliza and Mustafar, Ruslinda and M Saud, Muhammad Nordin},
  title = {Therapeutic drug monitoring-guided piperacillin dosing in critically ill patients undergoing continuous renal replacement therapy: a systematic review},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  volume = {79},
  number = {12},
  pages = {3078--3090},
  doi = {10.1093/jac/dkae332}
}
Kostenlos starten →